Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Galapagos reports topline results from phase Ib study of GLPG-1972 in osteoarthritis

Jan. 9, 2018

BioCryst Pharmaceuticals begins IND-enabling studies of two lead candidates

Jan. 9, 2018

Galapagos and Servier report ADAMTS inhibitors for osteoarthritis

Jan. 2, 2018

Patient recruitment ongoing in phase II trial of CR-6086

Dec. 29, 2017

Clover Biopharmaceuticals receives approval to initiate clinical trials of SCB-808 in China

Dec. 28, 2017

Phase II study of anabasum in SLE begins

Dec. 27, 2017

UCB reports phase IIb data on bimekizumab in psoriatic arthritis

Dec. 21, 2017

AbbVie reports topline results from phase III study of upadacitinib

Dec. 21, 2017

Fresenius submits first biosimilar MAA to EMA

Dec. 19, 2017

Izana Bioscience launches, obtains rights to Takeda's namilumab for ankylosing spondylitis

Dec. 18, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026